THE EPIGENETIC PROTECTION SHELL OF EUCHROMATIN DNA

Oxygen exists in two gaseous (dioxygen and ozone) and six solid allotropic modifications. An additional allotropic modification of oxygen, the cyclooctaoxygen, was predicted to exist in 1990. The first synthesis and characterization of cyclooctaoxygen as its sodium crown complex, isolated in the form of three cytosine nucleoside hydrochloride complexes, was reported in 2016. Cyclooctaoxygen sodium was synthesized in vitro from atmospheric oxygen, or catalase effect-generated oxygen, under catalysis of cytosine nucleosides and either ninhydrin or eukaryotic low-molecular weight RNA. Thin-layer chromatographic mobility shift assays were applied on specific nucleic acids and the cyclooctaoxygen sodium complex. The cationic cyclooctaoxygen sodium complex was shown to bind to nucleic acids (RNA and DNA), to associate with single-stranded DNA and spermine phosphate, and to be essentially non-toxic to cultured mammalian cells at 0.11.0 mM concentration. It is postulated that cyclooctaoxygen is formed in most eukaryotic cells in vivo from dihydrogen peroxide in a catalase reaction catalysed by cytidine and RNA. A molecular biological model was deduced for a first epigenetic shell of eukaryotic in vivo DNA. This model incorporates an epigenetic explanation for the interactions of the essential micronutrient selenium (as selenite) with eukaryotic in vivo DNA. The sperminium hydrogen phosphate/cyclooctaoxygen sodium complex is calculated to cover the actively transcribed regions (2.6%) of bovine lymphocyte interphase genome. Cyclooctaoxygen seems to be naturally absent in hypoxia-induced highly condensed chromatin, taken as a model for eukaryotic metaphase/anaphase/early telophase mitotic chromatin. Hence, it is proposed that the cyclooctaoxygen sodium-bridged sperminium hydrogen phosphate and selenite coverage serves as an epigenetic shell of actively transcribed gene regions in eukaryotic 'open' euchromatin DNA. It is proposed that the sperminium phosphate/cyclooctaoxygen sodium complex coverage of nucleic acids is essential to eukaryotic gene regulation and promoted proto-eukaryotic evolution. Cyclooctaoxygen sodium-bridged sperminium hydrogen selenite is calculated to serve as a marker shell component at ATG start codons in human euchromatin DNA mRNA genes, both at the translation initiation triplet and at 5-untranslated region upstream ATGs. The total herbicide glyphosate (ROUNDUP®) and its metabolite (aminomethyl)phosphonic acid (AMPA) are proved to represent 'epigenetic poisons', since they both selectively destroy the cyclooctaoxygen sodium complex. This definition is of reason, since the destruction of cyclooctaoxygen is certainly sufficient to bring the protection shield of human euchromatin into collateral epigenetic collapse. The total herbicide glyphosate and its environmental metabolite (aminomethyl)phosphonic acid (AMPA) can be associated in vitro with catalytic detoriation of eukaryotic euchromatin genetic information. The epigenetic shell of eukaryotic euchromatin is susceptible to decay induced by catalytic epigenetic poisons threatening eukaryotic genomic heritage.

The purpose of this book is to shed light onto the obscurities of the polyamine spermine and the essential micronutrient selenium in human and, more generally, eukaryotic nucleic acid biochemistry and molecular (epi)genetics. An important (epi)genetic structure contribution towards the molecular biological discrimination between eukaryotic euchromatin and heterochromatin will be deduced, scientifically confirmed and described in this book. The book is also needed for information and risk evaluation regarding the totel herbicide glyphosate; strict molecular biologic methodology; new research presented; highly innovative results by honest and controlled research.

Auteur
1990 ABITUR. 19911993 CHEMISTRY SCHOOL DR. ERWIN ELHARDT, STUDY OF CHEMICAL-TECHNICAL ASSISTANT (CTA). 1993 PRACTICAL TRAINING, MAX-PLANCK-INSTITUTE FOR BIOCHEMISTRY, MARTINSRIED, GERMANY, DEPARTMENT OF PROTEIN CHEMISTRY OF DR. FRIEDRICH LOTTSPEICH, IN THE FORMER LABORATORY OF DR. PEHR VICTOR EDMAN (ADVISOR: KERSTIN ANDERSSON, GENERAL TRAINING IN PROTEIN CHEMISTRY, ELECTROPHORESIS, AND PROTEIN SEQUENCING BY THE EDMAN METHOD). 1993 PRACTICAL TRAINING, MAX-PLANCK-INSTITUTE FOR NEUROBIOLOGY, MARTINSRIED, GERMANY, DEPARTMENT OF NEUROIMMUNOLOGY OF PROF. DR. DR. H.C. HARTMUT WEKERLE (ADVISOR: DR. ANTONIO IGLESIAS, TRAINING IN MOLECULAR BIOLOGY AND DNA SEQUENCING). 19931995 WORK AS CHEMICAL-TECHNICAL ASSISTANT AT MAX-PLANCK-INSTITUTE FOR BIOCHEMISTRY IN THE DEPARTMENT OF VIRUS RESEARCH OF PROF. DR. DR. DR. H.C. PETER HANS HOFSCHNEIDER, WITH SPECIAL TRAINING IN THE MOLECULAR BIOLOGY OF HUMAN HEPATITIS B VIRUS. 19952000 STUDY OF PHARMACY AT LUDWIG-MAXIMILIANS-UNIVERSITY, MUNICH, GERMANY. 20042005 STUDY OF PHARMACY AT JULIUS-MAXIMILIANS UNIVERSITY OF WÜRZBURG, GERMANY. 20062011 DOCTORAL STUDY AT JULIUS-MAXIMILIANS UNIVERSITY OF WÜRZBURG, GERMANY, IN THE DEPARTMENT OF PHARMACEUTICAL CHEMISTRY OF PROF. DR. ULRIKE HOLZGRABE. 20112015 PUBLICATION WORK AS PRIVATE RESEARCHER IN MUNICH, GERMANY. 20152017 WORK AS CHIEF MEDICINAL CHEMIST FOR POP TEST ONCOLOGY LLC OF RANDICE LISA ALTSCHUL, CLIFFSIDE PARK, NJ, USA. 1998 ELECTION AS AN EXTERNAL MEMBER OF THE NEW YORK ACADEMY OF SCIENCES, NEW YORK, USA. 2005 MEMBER OF THE AMERICAN CHEMICAL SOCIETY, DIVISION OF MEDICINAL CHEMISTRY. 18 PUBLICATIONS AND/OR CONGRESS ABSTRACTS IN PEER-REVIEWED JOURNALS. 2 BOOKS PUBLISHED. 30 CO-AUTHORED PATENTS.